Biomarkers, such as carbohydrate antigen 125 (CA125), carbohydrate antigen 19–9 (CA19-9), and carcinoembryonic antigen (CEA), all have potential value in early-stage ovarian cancer detection. Here, CEACAM5 is linked to ovarian cancer.